Zusammenfassung
Die konventionelle manuelle Kompression mit anschließendem Druckverband zum Verschluß der arteriellen Punktionsstelle nach diagnostischer Herzkatheteruntersuchung oder Koronarintervention ist mit einer mehrstündigen Immobilisation des Patienten verbunden. Die routinemäßige Antikoagulation sowie der Einsatz großlumiger Schleusen und Plättcheninhibitoren sind von einer erhöhten Inzidenz lokaler Blutungskomplikationen begleitet. Die sofortige Schleusenentfernung noch auf dem Kathetertisch mit sicherem Verschluß der Punktionsstelle ist wünschenswert und führt zu einem gesteigerten Wohlbefinden des Patienten. Das Angio-Seal™-System basiert auf einem hämostatischen Verschluß der Punktionsstelle mittels resorbierbarem Anker und Kollagenpfropf. In mehreren Studien wurden die Sicherheit und Effektivität des Systems dokumentiert. Dabei werden Erfolgsraten zwischen 88 und 100% berichtet. Signifikant reduzierte Hämostasezeiten ermöglichen eine frühzeitigere Mobilisation und verkürzte stationäre Aufenthaltsdauer des Patienten im Vergleich zur manuellen Kompression, ohne daß Komplikationen vermehrt auftraten.
Abstract
Conventional manual compression and subsequent application of pressure bandages is associated with prolonged immobility and significant patient discomfort. Routine anticoagulation as well as the use of new interventional devices and platelet inhibiting strategies lead to a higher incidence of local bleeding complications after diagnostic cardiac catheterization or coronary angioplasty. Immediate sheath removal increases patient comfort.
The Angio-Seal™ system uses a biodegradable anchor and collagen plug for sealing of arterial puncture sites. Several studies showed the safety and efficacy of this device. Technical deployment success ranges between 88 and 100%. Significant reduction in time to hemostasis allows for earlier patient ambulation and shorter in-hospital stay compared to manual compression with peripheral complications not being increased.
Literatur
Aguirre FV, Topol EJ, Ferguson JJ, et al. Bleeding complications with the chimeric antibody to platelet glycoprotein IIb/IIIa integrin in patients undergoing percutaneous coronary intervention. Circulation 1995;91:2882–90.
Aker UT, Kensey KR, Heuser RR, et al. Immediate arterial hemostasis after cardiac catheterization: initial experience with a new punture closure device. Cathet Cardiovasc Diagn 1994; 31:228–31.
Blankenship JC, Hellkamp AS, Aguirre FV, et al. for the EPIC investigators. Vascular access site complications after percutaneous coronary interventions with abeiximab in the evaluation of c7E3 for the prevention of ischemic complications (EPIC) trial. Am J Cardiol 1998;81:36–40.
Carere RG, Webb JG, Ahmed T, et al. Initial experience using Prostar™: A new device for percutaneous suture-mediated closure of arterial puncture sites. Cathet Cardiovasc Diagn 1996;37:367–72.
Chevalier B, Glatt B, Guyon P, et al. First european experience of 6 Fr Angioseal in diagnostic procedures. Am J Cardiol 1999; 84:338.
Chevalier B, Lancelin B, Berthaux X. Hemostatic puncture closure device versus regular compression: a randomized study. J Am Coll Cardiol 1995;25:Suppl:93A.
Cooper CL, Miller A. Infectious complications related to the use of the Angio-Seal hemostatic puncture closure device. Cathet Cardiovasc Intervent 1999;48:301–3.
Cremonesi A, Castriota F, Tarantino F, et al. Femoral arterial hemostasis using the Angio-Seal™ system after coronary and vascular percutaneous angioplasty and stenting. J Invas Cardiol 1998;10:464–9.
De Swart H, Dijkman L, Hofstra L, et al. A new hemostatic puncture closure device for the immediate sealing of arterial puncture sites. Am J Cardiol 1993;72:445–9.
Dick RJ, Popma JJ, Muller DW, et al. In hospital costs associated with new percutaneous coronary devices. Am J Cardiol 1991;68:879–85.
Eidt JF, Saucedo J, Moursi M, et al. Surgical complications from hemostatic puncture closure devices. Am J Cardiol 1999;84:TCT 143.
Ernst S, Tjonjoegrin RM, Schräder R, et al. Immediate sealing of arterial puncture sites after cardiac catheterization and coronary angioplasty using a biodegradable collagen plug: results of an international registry. J Am Coll Cardiol 1993;21:851–5.
Fischman DL, Leon MB, Baim DS, et al. A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994;331: 496–501.
Gerckens U, Cattelaens N, Müller R, et al. Perkutaner Nahtverschluß von Femoralarterienzugängen nach diagnostischer Herzkatheteruntersuchung oder Koronarintervention. Dtsch Med Wochenschr 1996;121:1487–91.
Gershony G, Brock JM, Powell JS. A novel vascular sealing device for closure of percutaneous vascular access sites. Cathet Cardiovasc Diagn 1998;45:82–8.
Gonze MD, Sternbergh WC, Salartash K, et al. Complications associated with percutaneous closure devices. Am J Surg 1999;178:209–11.
Henry M, Amor M, Allaoui M, et al. A new access site management tool: the Angio-Seal™ hemostatic puncture closure device. J Endovasc Surg 1995;2:289–96.
Kazmouz G, Ali A, LaLaonde T, et al. The safety of routine use of a femoral artery implantable device (Angio-Seal) after coronary angioplasty and stenting. Am J Cardiol 1999;84:TCT 141.
Kensey KR, Evans DE, McGill LD, et al. In vivo feasibility testing of a bioresorbable hemostatic puncture closure device. J Am Coll Cardiol 1991;17:263A.
Kern MJ, Cohen M, Talley JD, et al. Early ambulation after 5 F diagnostic cardiac catheterization: results of a multicenter trial. J Am Coll Cardiol 1990;15:1475–83.
Klinke NP, Kubac G, Talibi T, et al. Safety of outpatient cardiac catheterization. Am J Cardiol 1985;56:639–41.
Krause PB, Klein LW. Utility of a percutaneous collagen hemostasis device: To plug or not to plug? Am J Cardiol 1993;22:1280–2.
Kussmaul WG 3rd, Buchbinder M, Whitlow PL, et al. Rapid arterial hemostasis and decreased access site complications after cardiac catheterization and angioplasty: results of a randomized trial of a novel hemostatic device. J Am Coll Cardiol 1995;25:1685–92.
Kussmaul WG, Buchbinder M, Whitlow P, et al. Femoral artery hemostasis using an implantable device (Angio-Seal™) after coronary angioplasty. Cathet Cardiovasc Diagn 1996;37:362–5.
Lübkemann H, Haude M, Görge G, et al. Immediate closure of femoral artery puncture site after cardiac catheterization by a new collagen- anchor device (Angio-Seal™): results in 1818 consecutive patients. Am J Cardiol 1997;80:255.
Meyners W, Fassbender D, Danch E, et al. Hochgradige Stenosen und Verschlüsse der Arteria femoralis nach Anwendung von Angio-Seal™ bei Herzkatheteruntersuchung und Katheterinterventionen. Z Kardiol 1999;88:Suppl I:27.
Meyners W, Fassbender D, Gleichmann U, et al. Hämostatischer Verschluß der arteriellen Punktionsstelle mit Angio-Seal™ nach percutaner transluminaler Coronarangioplastie (PTCA) und adjuvanter Gabe von abciximab (ReoPro©). Z Kardiol 1999;88: Suppl I:26.
Mooney MR, Ellis SE, Yehyawi KJ, et al. Immediate sealing of arterial puncture sites after cardiac catheterization and coronary interventions: initial U.S. feasibility trial using the DUETT vascular closure device. Circulation 1998;98:1–88.
Muller DWM, Shamir KF, Ellis SG, et al. Peripheral vascular complications after conventional and complex percutaneous interventional procedures. Am J Cardiol 1992;69:63–8.
Murray CR, Mortazavi A, Warth DC, et al. A randomized controlled prospective study of the Angio-Seal device versus manual pressure for rapid arterial puncture closure. Circulation 1996;94:Suppl I:2192.
O’Sullivan GJ, Buckenham TM, Belli AM. The use of the Angio-Seal haemostatic puncture closure device in high risk patients. Clin Radiol 1999;54:51–5.
Omuigui NA, Califf RM, Pieper K, et al. Peripheral vascular complications in the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT-1). J Am Coll Cardiol 1995; 26:922–30.
Popma JJ, Satler LF, Pichard AD, et al. Vascular complications after balloon and new device angioplasty. Circulation 1993;88: 1569–78.
Rodes J, Cotes G, Bilodeau L, et al. Early ambulation after percutaneous transluminal coronary angioplasty: a prospective randomized trial comparing manual compression and the 8F Angio-Seal™ hemostatic device. Am J Cardiol 1997;80:43.
Sakthi C, Sebastian M, Eigler N, et al. Use of the Angio-Seal following percutaneous coronary interventions with abciximab improves times to ambulation and discharge. Am J Cardiol 1999;84:TCT 138.
Sanborn TA, Gibbs HH, Brinker JA, et al. A multicenter randomized trial comparing a percutaneous collagen hemostasis device with conventional manual compression after diagnostic angiography and angioplasty. J Am Coll Cardiol 1993;22:1273–9.
Seidelin PH, Adelman AG. Mobilization within thirty minutes of elective diagnostic coronary angiography: a feasibility study using a hemostatic femoral puncture closure device. J Intervent Cardiol 1997;10:409–15.
Silber S, Dörr R, Mühling H, et al. Sheath pulling immediately after PTCA: comparison of two different techniques for the hemostatic puncture closure device: a prospective, randomized study. Cathet Cardiovasc Diagn 1997;41:378–83.
Silber S, Schön N, Seidel N, et al. Akidenteller Verschluß einer A. femoralis communis nach Angio-Seal™ Applikation. Z Kardiol 1998;87:51–5.
Silber S. Hemostasis success rates and local complications with collagen after femoral access for cardiac catheterization: analysis of 6007 published cases. Am Heart J 1998;135:152–6.
Steinkamp HJ, Scheinert D, Hettwer M, et al. PTLA-Rekanalisation von Femoralarterienstenosen/-okklusionen nach Angio-Seal™ Applikation. Fortschr Röntgenstr 1999;170:105–8.
Szto GYF, Rothbaum DA, Wong SC, et al. for the Angio-Seal Stent Early Ambulation Trial Investigators. Early ambulation a after coronary stenting — prospective randomized trial of Angio-Seal hemostatic puncture closure device versus manual compression: interim analysis. Am J Cardiol 1997;80:252.
The EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994;330:956–61.
Tomlinson MA, Beese R, Banwell M, et al. Sequential retroperitoneal venous hemorrhage and embolism of an angio- seal puncture closure device complicating iliac artery angioplasty. J Endovasc Surg 1999;6:264–9.
Waksman R, King SB, Douglas JS, et al. Predictors of groin complications after balloon and new- device coronary intervention. Am J Cardiol 1995;75:886–9.
Ward SR, Casale P, Raymond R, et al. for the Angio-Seal Investigators. Efficacy and safety of a hemostatic puncture closure device with early ambulation after coronary angiography. AM J Cardiol 1998;81:569–72.
Warren BS, Warren SG, Miller SD. Predictors of complications and learning curve using the Angio-Seal™ closure device following interventional and diagnostic catheterization. Cathet Cardiovasc Intervent 1999;48:162–6.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Eggebrecht, H., Haude, M., Baumgart, D. et al. Hämostatischer Verschluß der arteriellen Punktionsstelle mittels Angio-Seal™ nach diagnostischer Herzkatheteruntersuchung oder Koronarintervention. Herz 24, 607–613 (1999). https://doi.org/10.1007/BF03044484
Issue Date:
DOI: https://doi.org/10.1007/BF03044484